(Q40896227)

24 September 2017

1 reference

title

Pulmonary hypertension in systemic autoimmune disease (English)

1 reference

24 September 2017

1 reference

Gurubhagavatula I

1

1 reference

24 September 2017

Palevsky HI

series ordinal

2

1 reference

24 September 2017

publication date

1 May 1997

1 reference

Rheumatic Diseases Clinics of North America

24 September 2017

published in

1 reference

24 September 2017

volume

23

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

365-394

1 reference

Cardiovascular manifestations of mixed connective tissue disease in adults.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary hypertension in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary hypertension in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Role of prostacyclin in the treatment of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Vasodilators and primary pulmonary hypertension. Variability of long-term response

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Long‐term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Echo/Doppler and hemodynamic correlates of vasodilator responsiveness in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Raynaud's phenomenon of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary Vascular Disease in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Long-term home oxygen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Primary pulmonary hypertension: natural history and the importance of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Role of pharmacologic tests in the treatment of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary thromboembolism: recent developments in diagnosis with CT and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary manifestations associated with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Echocardiographic evaluation of patients with clinically suspected arterial emboli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary hypertension and autoimmune disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Unexplained pulmonary hypertension with pulmonary arteritis in rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Diagnosing Pulmonary Embolism: New Facts and Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Heterogeneity of pathologic lesions in familial primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary hypertension in a patient with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Hemodynamic effects of captopril in pulmonary hypertension of collagen vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary angiography in severe chronic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Autoantibody to U3 Nucleolar Ribonucleoprotein (Fibrillarin) In Patients with Systemic Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Prostacyclin and acetylcholine as screening agents for acute pulmonary vasodilator responsiveness in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

A Study of Etiologic Factors in So-Called Primary Pulmonary Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Medical treatment of primary pulmonary hypertension: a bridge to transplantation?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Antinuclear antibodies in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Characteristics of surviving and nonsurviving patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pathology and pathophysiology of primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pleuropulmonary manifestations of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Appetite suppressants and primary pulmonary hypertension in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

DISTRIBUTION OF BLOOD FLOW IN ISOLATED LUNG; RELATION TO VASCULAR AND ALVEOLAR PRESSURES

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

Pulmonary vascular changes in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

The pulmonary pathologic manifestations of the CREST syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970335-5

7 January 2021

10.1016/S0889-857X(05)70335-5

Identifiers

DOI

1 reference

24 September 2017

1 reference